Examination of the end time of limaprost treatment for lumbar spinal canal stenosis

Examination of the end time of limaprost treatment for lumbar spinal canal stenosis - Examination of the end time of limaprost treatment for lumbar spinal canal stenosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008776

Enrollment

100

Registered

2012-08-27

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar spinal canal stenosis

Interventions

Group to continue the limaprost administration after the onset of effect limaprost. Group to discontinue treatment after the onset limaprost effect.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Acquired lumbar spinal canal stenosis 2.Patients presenting with intermittent claudication of attitude 3.Capable of giving informed consent

Exclusion criteria

Exclusion criteria: 1.Patients with hypersensitivity to limaprost 2.Patients with bleeding tendency 3.Patients on anticoagulation therapy with other drugs 4.Patients with ASO 5.Patients suspected of being pregnant or pregnancy 6.Patients who were recognized unsuitable for this study by primary physician

Design outcomes

Primary

Measure	Time frame
Distance and time of intermittent claudication(m,min) Symptoms (pain, numbness)	—

Secondary

Measure	Time frame
JOA back pain evaluation questionnaire Satisfaction of daily life	—

Countries

Japan

Contacts

Public ContactTomohiko Hasegawa

Hamamatsu University School of Medicine Department of Orthopedics

hasetomo@hama-med.ac.jp053-435-2299

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026